Heart Inflammation Risk Higher From Moderna Vaccine Than COVID-19 for Those Under 40: Study
December 15, 2021 Updated: December 15, 2021
The risk of developing a form of heart inflammation is higher for people younger than 40 after receiving Moderna’s COVID-19 vaccine than it is from contracting COVID-19, according to a new study.
Researchers found 15 excess cases per 1 million people who received a second dose of the vaccine compared to 10 extra cases of myocarditis following a positive COVID-19 test. Moderna’s vaccine is typically taken in a two-dose regimen.
The risk of myocarditis, a form of heart inflammation, was much higher following the second dose of the Moderna vaccine, but there were still eight excess cases per 1 million people following the first dose as well.
“Time to abandon the belief that COVID-19 myocarditis risk is always higher than mRNA vaccine myocarditis risk. For some individuals, myocarditis risks of the vaccine(s) are higher than those of the disease,” Euzebiusz Jamrozik, an infectious disease expert who works at the University of Oxford, wrote on Twitter. CONTINUE READING >>>
